Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > The additional ring is one of the cyclos in a polycyclo ring system > Hetero ring in the polycyclo ring system > Plural hetero atoms in the polycyclo ring system > Plural ring nitrogens in the polycyclo ring system > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/322
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > The additional ring is one of the cyclos in a polycyclo ring system > Hetero ring in the polycyclo ring system > Plural hetero atoms in the polycyclo ring system > Plural ring nitrogens in the polycyclo ring system
Description: Subject matter wherein the polycyclo ring system contains at least two ring nitrogen atoms.

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number	Title Of Patent	Date Issued
6187794	Methods for treating allergic disorders and other disorders using norastemizole	Feb. 13, 2001
6187795	Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients	Feb. 13, 2001
6184235	2-phenyl benzimidazole derivatives as MCP-1 antagonists	Feb. 6, 2001
6180649	1-(4-piperidyl)-benzimidazoles having neurotrophic activity	Jan. 30, 2001
RE37029	N-[(3-heteroaryl-1-pyrrolidinyl)-alkyl]phthalimides and related compounds and their therapeutic utility	Jan. 23, 2001
6172067	2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists	Jan. 9, 2001
6172073	Compounds having effects on serotonin-related systems	Jan. 9, 2001
6172085	Cyclic ether compounds as sodium channel modulators	Jan. 9, 2001
6162804	Tyrosine kinase inhibitors	Dec. 19, 2000
6153634	4,5-azolo-oxindoles	Nov. 28, 2000
6143767	Piperidinylamino tricyclic compounds as substance P antagonists	Nov. 7, 2000
6143747	Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors	Nov. 7, 2000
6140345	1-(aryloxyalkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics	Oct. 31, 2000
6140349	Cyclic amine modulators of chemokine receptor activity	Oct. 31, 2000
6136826	Peripheral vasodilating agent containing piperidine derivative as active ingredient	Oct. 24, 2000
6136827	Cyclic amine modulations of chemokine receptor activity	Oct. 24, 2000
6133290	5-HT.sub.1F agonists	Oct. 17, 2000
6130233	Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole	Oct. 10, 2000
6130217	Compounds enhancing antitumor activity of other cytotoxic agents	Oct. 10, 2000
6130234	4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists	Oct. 10, 2000
6130235	Compounds and methods to treat cardiac failure and other disorders	Oct. 10, 2000
6127384	Compounds, compositions and methods for treatment of hepatitis C	Oct. 3, 2000
6124321	Heteroaryl amines as novel acetyl cholinesterase inhibitors	Sep. 26, 2000
6124320	Methods for treating allergic disorders using norastemizole	Sep. 26, 2000
6114327	Anti-viral compounds	Sep. 5, 2000
6110939	(Benzimidazolyl- and imidazopyridinyl) containing 1-(1,2-disubstituted piperidinyl) derivatives	Aug. 29, 2000
6110935	Benzofurazan compounds for enhancing glutamatergic synaptic responses	Aug. 29, 2000
6110938	1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics	Aug. 29, 2000
6107310	Heteroarylcarboxamide derivatives for treating CNS disorders	Aug. 22, 2000
6096761	Esters of 3-hydroxy-piperidinemethanol derivatives	Aug. 1, 2000
6096771	Isoxazole derivatives	Aug. 1, 2000
6096763	.alpha..sub.1a adrenergic receptor antagonists	Aug. 1, 2000
6093704	Use of dopamine receptor antagonists in palliative tumor therapy	Jul. 25, 2000
6090824	Therapeutic neurokinin receptor antagonist compounds	Jul. 18, 2000
6075039	5HT receptor binding benzimidazolylpiperidines	Jun. 13, 2000
6075026	Certain substituted 1-aryl-3-piperazin-1'-yl propanones	Jun. 13, 2000
6071909	Phenylbenzimidazole derivatives as ligands for GABA receptors	Jun. 6, 2000
6069152	5-HT.sub.4 agonists and antagonists	May. 30, 2000
6066650	Inhibitors of microsomal triglyceride transfer protein and method	May. 23, 2000
6063795	Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors	May. 16, 2000
6063796	Somatostatin agonists	May. 16, 2000
6051572	Azetidine, pyrrolidine and piperidine derivatives	Apr. 18, 2000
6046205	Indole and indazole compounds	Apr. 4, 2000
6043240	3-heteroaryl-1-pyrrolidinealkylamines and derivatives thereof and their therapeutic utility	Mar. 28, 2000
6034079	Nicotine antagonists for nicotine-responsive neuropsychiatric disorders	Mar. 7, 2000
6030992	Methods of treating or preventing sleep apnea	Feb. 29, 2000
6025372	Somatostatin agonists	Feb. 15, 2000
6025378	Bicyclic heterocyclic compounds	Feb. 15, 2000
6020336	Indole and indazole compounds	Feb. 1, 2000
5998439	Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases	Dec. 7, 1999